UOTTAIMCU
NBIX icon

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Neurocrine Biosciences NBIX Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Sell
7,192
-10,844
-60% -$1.61M 0.14% 92
2026
Q1 		$2.38M Buy
18,036
+6,840
+61% +$908K 0.35% 59
2025
Q4 		$1.59M Sell
11,196
-4,078
-27% -$591K 0.22% 73
2025
Q3 		$2.14M Buy
+15,274
New +$2.07M 0.31% 54

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s NBIX Position: Q2 2026 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) reduced its Neurocrine Biosciences (NBIX) stake by 60% in Q2 2026, selling an estimated $1.61M and leaving 7,192 shares worth $1.21M. The position accounts for 0.14% of the portfolio, ranked #92.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in NBIX in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.38M in Q1 2026. 772 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) held 7,192 shares of Neurocrine Biosciences worth $1.21M as of Q2 2026.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 10,844 Neurocrine Biosciences shares in Q2 2026, an estimated $1.61M.
  • Neurocrine Biosciences made up 0.14% of University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio in Q2 2026, its #92 holding.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Neurocrine Biosciences in Q3 2025 and has held it in 4 quarters since.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s Neurocrine Biosciences position peaked at $2.38M in Q1 2026.
  • 772 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.